+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

How to Approach a Patient With Limited Stage Hodgkin Lymphoma Who Remains PET Positive at the End of Chemotherapy: Radiation Therapy?

How to Approach a Patient With Limited Stage Hodgkin Lymphoma Who Remains PET Positive at the End of Chemotherapy: Radiation Therapy?

Clinical Lymphoma, Myeloma and Leukemia 17(11): 710-715

The use of 18-F fluorodeoxyglucose (FDG) positron emission tomography (PET) with computed tomography has emerged as a crucial tool for response-adapted therapy in Hodgkin lymphoma (HL). Although more studies have focused on the predictive value of an interim or early PET obtained after 2 cycles of chemotherapy, there are indications that the end of therapy PET might even be more predictive of outcome. The optimal treatment of patients with limited stage HL who are PET-positive after chemotherapy is unknown. Here we review the prognostic significance of end of treatment PET in early stage HL, the role of consolidative radiotherapy in patients who have FDG-PET avidity at the end of chemotherapy, and discuss the place of salvage chemotherapy and autologous transplantation in these patients.

(PDF emailed within 0-6 h: $19.90)

Accession: 059811579

Download citation: RISBibTeXText

PMID: 28711575

DOI: 10.1016/j.clml.2017.06.019

Related references

Stage IA non-Hodgkin's lymphoma of the Waldeyer's ring: Limited chemotherapy and radiation therapy versus radiation therapy alone. Acta Oncologica (Stockholm) 32(6): 675-678, 1993

Treatment of favorable, limited-stage Hodgkin's lymphoma with chemotherapy without consolidation by radiation therapy. Journal of Clinical Oncology 28(9): 1611-1615, 2010

Clinical trials report. Comparison of ABVD chemotherapy and a regimen including radiation therapy in patients with limited-stage non-Hodgkin's lymphoma. Current Oncology Reports 8(5): 354-357, 2006

ABVD alone versus radiation-based therapy in limited-stage Hodgkin's lymphoma. New England Journal of Medicine 366(5): 399-408, 2012

Randomized comparison of ABVD chemotherapy with a strategy that includes radiation therapy in patients with limited-stage Hodgkin's lymphoma: National Cancer Institute of Canada Clinical Trials Group and the Eastern Cooperative Oncology Group. Journal of Clinical Oncology 23(21): 4634-4642, 2005

Involved-nodal radiation therapy as a component of combination therapy for limited-stage Hodgkin's lymphoma: a question of field size. Journal of Clinical Oncology 26(32): 5170-5174, 2008

Rituximab followed by localized radiation therapy in limited stage indolent non-Hodgkin's lymphoma: Preliminary results of a pilot study. Journal of Clinical Oncology 23(16_suppl): 6696-6696, 2016

Brief chemotherapy and involved field radiation therapy for limited stage histologically aggressive lymphoma. Annals of Internal Medicine 107(1): 25-30, 1987

Improved survival in patients with limited stage IIIA Hodgkin's disease treated with combined radiation therapy and chemotherapy. Journal of Clinical Oncology 12(12): 2567-2572, 1994

An individual patient-data comparison of combined modality therapy and ABVD alone for patients with limited-stage Hodgkin lymphoma. Annals of Oncology 24(12): 3065-3069, 2014

Consolidative radiation therapy for stage III Hodgkin lymphoma in patients who achieve complete response after ABVD chemotherapy. American Journal of Clinical Oncology 34(5): 499-505, 2011

Chemotherapy followed by consolidation radiation therapy for the treatment of clinical stage II aggressive histologic type non-Hodgkin's lymphoma. Cancer 61(9): 1754-1758, 1988

Balancing risks and benefits of therapy for patients with favorable-risk limited-stage Hodgkin lymphoma: the role of doxorubicin, bleomycin, vinblastine, and dacarbazine chemotherapy alone. Hematology/Oncology Clinics of North America 28(1): 49-63, 2014

Involved-lesion radiation therapy after chemotherapy in limited-stage head-and-neck diffuse large B cell lymphoma. International Journal of Radiation Oncology, Biology, Physics 78(2): 507-512, 2010

Reduced Mortality Risk in the Recent Era in Early-Stage Hodgkin Lymphoma Patients Treated With Radiation Therapy With or Without Chemotherapy. International Journal of Radiation Oncology, Biology, Physics 100(2): 498-506, 2017